Shapiro Benjamin has filed 6 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 30000 shares of ORAMED PHARMACEUTICALS INC. ($ORMP) on December 31, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Shapiro Benjamin | Director | A | Common Stock | 30000 | $0.00 | 2,019,720.0000 | 42,774,504 | 1.51% | 0.07% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Shapiro Benjamin | Director | A | Common Stock | 3500 | $0.00 | 2,023,220.0000 | 42,774,504 | 0.17% | 0.01% |
| June 5, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Shapiro Benjamin | Director | A | Common Stock | 30000 | $0.00 | 1,985,070.0000 | 41,228,782 | 1.53% | 0.07% |
| June 5, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Shapiro Benjamin | Director | A | Common Stock | 4650 | $0.00 | 1,989,720.0000 | 41,228,782 | 0.23% | 0.01% |
| Jan. 4, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Shapiro Benjamin | Director | A | Common Stock | 30000 | $0.00 | 1,950,000.0000 | 40,566,901 | 1.56% | 0.07% |
| Jan. 4, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Shapiro Benjamin | Director | A | Common Stock | 5070 | $0.00 | 1,955,070.0000 | 40,566,901 | 0.26% | 0.01% |